UNSPSC 85711508: Revision of nonautologous tissue substitute in right acromioclavicular joint, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of nonautologous tissue substitute in right acromioclavicular joint, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0RWG4KZ

UNSPSC 85711508 Revision of nonautologous tissue substitute in right acromioclavicular joint, percutaneous endoscopic approach is a Commodity code that does not align with the recent state and local procurement activity tagged under it. The six opportunities posted between July and September 2026 span independent medical evaluation services for disability pension determinations, surgical benefits administration, occupational medical surveillance, emergency and specialty healthcare for detained youth, pharmacy benefit management, and temporary health professional staffing — none of which involve orthopedic tissue substitutes or joint procedures. The code's nominal scope describes a specific surgical procedure on the shoulder joint, but the state and local opportunities classified under it are administrative and clinical staffing or benefit-management services without any connection to that procedure. This mismatch suggests either a data-entry error in how opportunities were tagged or a fundamental misalignment between the code definition and how state and local procurement offices are applying it in practice.

The issuing bodies include a city pension board (Phoenix), two cities (Long Beach, Seattle area), a county health system (Santa Clara), a county juvenile probation department (Harris County), and a county benefits administration office (Collier County), reflecting typical state and local healthcare and benefits purchasers. The geographic spread encompasses Arizona, California, Washington, Texas, and Florida. Without opportunities that actually match the code's procedural scope, there is no decision-relevant recent activity to evaluate for firms providing orthopedic surgical materials or tissue-substitute products.